Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JP-1366 vs Esomeprazole for Reflux Esophagitis
NCT06850480Phase 3Recruiting
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Dec 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zastaprazan in reflux esophagitis, sponsored by Livzon Pharmaceutical Group Inc.. Started Dec 2024; status: recruiting.
02
Drugs
zastaprazan
03
Conditions
reflux esophagitis
Beyond the preview
Go deeper on NCT06850480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06850480.